Neurology · Maitland, FL
NPI
1952390452
Since 2005
Specialty
Neurology
Code 174400000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
301 N Maitland Ave
Maitland, FL, 32751
Phone (407) 647-5996
Groups this clinician bills Medicare through
Medicare paid, 2024
$941K
29,886 services
Medicare patients, 2024
1,395
Average age 76
Drug cost, 2024
$3.2M
7,925 prescriptions
Company payments, 2025
$4,993
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arnaldo Isa was code J0585 (injection, onabotulinumtoxina, 1 unit), 5,710 times for 11 patients. In total Arnaldo Isa billed 29,886 services in 57 codes, and Medicare paid $941K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,710 | 11 | $4.96 | $28K |
| 99214 Office E&M - Established | Office | 2,180 | 1,008 | $91.32 | $199K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,504 | 856 | $12.71 | $19K |
| 99213 Office E&M - Established | Office | 412 | 356 | $62.67 | $26K |
| 99204 Office E&M - New | Office | 339 | 339 | $125.57 | $43K |
| 99215 Office E&M - Established | Office | 158 | 133 | $138.11 | $22K |
| 95886 Electrical Nerve Conductivity | Office | 142 | 118 | $72.09 | $10K |
| 96365 Intravenous Infusion, Hydration | Office | 103 | 11 | $46.91 | $4,832 |
| 95909 Electrical Nerve Conductivity | Office | 88 | 88 | $100.56 | $8,850 |
| 95819 Neurologic | Office | 81 | 76 | $321.43 | $26K |
| 99205 Office E&M - New | Office | 66 | 66 | $164.41 | $11K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 63 | 56 | $41.23 | $2,597 |
| 95874 Musculoskeletal | Office | 41 | 15 | $55.11 | $2,259 |
| 95910 Electrical Nerve Conductivity | Office | 38 | 38 | $128.92 | $4,899 |
| 95885 Electrical Nerve Conductivity | Office | 35 | 23 | $45.90 | $1,606 |
By year: 2022 $1.6M for 46,105 services; 2023 $1.1M for 50,202 services; 2024 $941K for 29,886 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arnaldo Isa prescribed most often to Medicare patients was Donepezil Hcl, with 830 prescriptions and refills. In total Arnaldo Isa wrote 7,925 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 830 | 1,803 | 233 | $10K |
| Gabapentin Generic | 657 | 1,224 | 186 | $13K |
| Memantine Hcl Generic | 568 | 1,058 | 141 | $17K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 568 | 1,315 | 156 | $18K |
| Levetiracetam Generic | 287 | 640 | 73 | $9,949 |
| Buspirone Hcl Generic | 220 | 380 | 56 | $2,450 |
| Galantamine Er Galantamine Hbr | 208 | 426 | 52 | $17K |
| Pregabalin Generic | 190 | 308 | 49 | $6,226 |
| Rivastigmine Rivastigmine Tartrate | 186 | 352 | 45 | $14K |
| Lamotrigine Generic | 159 | 337 | 35 | $2,788 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 158 | 354 | 44 | $5,308 |
| Clonazepam Generic | 153 | 205 | 24 | $2,657 |
| Duloxetine Hcl Generic | 150 | 278 | 44 | $3,176 |
| Topiramate Generic | 129 | 245 | 33 | $2,829 |
| Sertraline Hcl Generic | 128 | 224 | 36 | $2,390 |
Brand drugs: - claims; generic drugs: 7,149 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arnaldo Isa $4,993 ($4,993 in general payments such as food, travel and fees) from 46 companies. The largest payer was Neurocrine BioSciences, Inc. with $699.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 37 | $699 |
| Abbvie Inc. ABBV | 25 | $446 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $372 |
| Pfizer Inc. PFE | 19 | $359 |
| Biogen, Inc. BIIB | 16 | $319 |
| Novartis Pharmaceuticals Corporation NVS | 42 | $288 |
| UCB, Inc. UCB.BR | 10 | $277 |
| Lundbeck LLC | 7 | $165 |
| EMD Serono, Inc. MRK.DE | 7 | $149 |
| Genzyme Corporation SNY | 6 | $146 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.